Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Abizaid

Showing results (121-130 of 306) with videos related to

Pageof 31
Sort By:
Circulation. Cardiovascular Interventions|January 22, 2015
Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trialDariusz Dudek, Artur Dziewierz, Sorin J Brener, et al.
Arquivos Brasileiros De Cardiologia|October 9, 2013
Miniaturized self-expanding drug-eluting stent in small coronary arteries: late effectivenessFlavio Roberto Azevedo de Oliveira, Luiz Alberto Piva E Mattos, Alexandre Abizaid, et al.
The American Journal of Cardiology|November 12, 2003
Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteriesIoannis Iakovou, Gary S Mintz, George Dangas, et al.
The American Journal of Cardiology|June 15, 2004
Angiographic and volumetric intravascular ultrasound comparison between direct sirolimus-eluting stent implantation versus predilationJuan S Muñoz, Alexandre Abizaid, Mariano Albertal, et al.
Journal of the American College of Cardiology|December 10, 2003
Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound studyIoannis Iakovou, Gary S Mintz, George Dangas, et al.
JACC. Cardiovascular Interventions|May 26, 2009
1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trialJ Ribamar Costa, Alexandre Abizaid, Ricardo Costa, et al.
The Journal of Invasive Cardiology|January 5, 2008
Intravascular ultrasound assessment of the novel AngioSculpt scoring balloon catheter for the treatment of complex coronary lesionsAlberto Fonseca, José de Ribamar Costa, Alexandre Abizaid, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 22, 2012
Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trialRicardo A Costa, Alexandre Abizaid, Andrea S Abizaid, et al.
Circulation|August 15, 2002
Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trialPatrick W Serruys, Muzaffer Degertekin, Kengo Tanabe, et al.
The Journal of Invasive Cardiology|June 23, 2020
Effect of Preloading With High Dose of Rosuvastatin on Serum Levels of Inflammatory Markers After Percutaneous Coronary InterventionJuliano R Slhessarenko, Mario Hirata, Amanda Sousa, et al.
Pageof 31

Showing results (121-130 of 306) with videos related to

Sort By:
Pageof 31
Circulation. Cardiovascular Interventions|January 22, 2015
Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trialDariusz Dudek, Artur Dziewierz, Sorin J Brener, et al.
Arquivos Brasileiros De Cardiologia|October 9, 2013
Miniaturized self-expanding drug-eluting stent in small coronary arteries: late effectivenessFlavio Roberto Azevedo de Oliveira, Luiz Alberto Piva E Mattos, Alexandre Abizaid, et al.
The American Journal of Cardiology|November 12, 2003
Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteriesIoannis Iakovou, Gary S Mintz, George Dangas, et al.
The American Journal of Cardiology|June 15, 2004
Angiographic and volumetric intravascular ultrasound comparison between direct sirolimus-eluting stent implantation versus predilationJuan S Muñoz, Alexandre Abizaid, Mariano Albertal, et al.
Journal of the American College of Cardiology|December 10, 2003
Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound studyIoannis Iakovou, Gary S Mintz, George Dangas, et al.
JACC. Cardiovascular Interventions|May 26, 2009
1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trialJ Ribamar Costa, Alexandre Abizaid, Ricardo Costa, et al.
The Journal of Invasive Cardiology|January 5, 2008
Intravascular ultrasound assessment of the novel AngioSculpt scoring balloon catheter for the treatment of complex coronary lesionsAlberto Fonseca, José de Ribamar Costa, Alexandre Abizaid, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 22, 2012
Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trialRicardo A Costa, Alexandre Abizaid, Andrea S Abizaid, et al.
Circulation|August 15, 2002
Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trialPatrick W Serruys, Muzaffer Degertekin, Kengo Tanabe, et al.
The Journal of Invasive Cardiology|June 23, 2020
Effect of Preloading With High Dose of Rosuvastatin on Serum Levels of Inflammatory Markers After Percutaneous Coronary InterventionJuliano R Slhessarenko, Mario Hirata, Amanda Sousa, et al.
Pageof 31